vs

Side-by-side financial comparison of Evolus, Inc. (EOLS) and OR Royalties Inc. (OR). Click either name above to swap in a different company.

Evolus, Inc. is the larger business by last-quarter revenue ($73.1M vs $46.7M, roughly 1.6× OR Royalties Inc.).

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

OR Royalties Inc. is a Canadian company that holds royalties in gold, silver and diamond mines, principally in the form of net smelter returns and streams.Like its predecessor company, Osisko Mining, it is headquartered in Montreal, Quebec, with shares listed on the Toronto Stock Exchange and the New York Stock Exchange.

EOLS vs OR — Head-to-Head

Bigger by revenue
EOLS
EOLS
1.6× larger
EOLS
$73.1M
$46.7M
OR

Income Statement — Q1 FY2026 vs Q2 FY2022

Metric
EOLS
EOLS
OR
OR
Revenue
$73.1M
$46.7M
Net Profit
$-10.7M
Gross Margin
66.9%
Operating Margin
23.8%
Net Margin
-14.6%
Revenue YoY
6.7%
Net Profit YoY
EPS (diluted)
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EOLS
EOLS
OR
OR
Q1 26
$73.1M
Q4 25
$90.3M
Q3 25
$69.0M
Q2 25
$69.4M
Q1 25
$68.5M
Q4 24
$78.9M
Q3 24
$61.1M
Q2 24
$66.9M
Net Profit
EOLS
EOLS
OR
OR
Q1 26
$-10.7M
Q4 25
$130.0K
Q3 25
$-15.7M
Q2 25
$-17.1M
Q1 25
$-18.9M
Q4 24
$-6.8M
Q3 24
$-19.2M
Q2 24
$-11.3M
Gross Margin
EOLS
EOLS
OR
OR
Q1 26
66.9%
Q4 25
65.7%
Q3 25
66.5%
Q2 25
65.3%
Q1 25
68.1%
Q4 24
66.7%
Q3 24
68.9%
Q2 24
70.3%
Operating Margin
EOLS
EOLS
OR
OR
Q1 26
23.8%
Q4 25
4.7%
Q3 25
-16.7%
Q2 25
-14.7%
Q1 25
-22.1%
Q4 24
-2.9%
Q3 24
-25.3%
Q2 24
-11.5%
Net Margin
EOLS
EOLS
OR
OR
Q1 26
-14.6%
Q4 25
0.1%
Q3 25
-22.8%
Q2 25
-24.7%
Q1 25
-27.6%
Q4 24
-8.6%
Q3 24
-31.4%
Q2 24
-17.0%
EPS (diluted)
EOLS
EOLS
OR
OR
Q1 26
$-0.16
Q4 25
$0.01
Q3 25
$-0.24
Q2 25
$-0.27
Q1 25
$-0.30
Q4 24
$-0.11
Q3 24
$-0.30
Q2 24
$-0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EOLS
EOLS
OR
OR
Cash + ST InvestmentsLiquidity on hand
$49.8M
Total DebtLower is stronger
$156.4M
$222.8M
Stockholders' EquityBook value
$1.3B
Total Assets
$220.6M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EOLS
EOLS
OR
OR
Q1 26
$49.8M
Q4 25
$53.8M
Q3 25
$43.5M
Q2 25
$61.7M
Q1 25
$67.9M
Q4 24
$87.0M
Q3 24
$85.0M
Q2 24
$93.7M
Total Debt
EOLS
EOLS
OR
OR
Q1 26
$156.4M
Q4 25
$146.1M
Q3 25
Q2 25
Q1 25
$121.8M
Q4 24
$121.5M
Q3 24
$121.2M
Q2 24
$120.9M
Stockholders' Equity
EOLS
EOLS
OR
OR
Q1 26
Q4 25
$-23.1M
Q3 25
$-28.8M
Q2 25
$-18.7M
Q1 25
$-6.6M
Q4 24
$5.5M
Q3 24
$5.9M
Q2 24
$19.3M
Total Assets
EOLS
EOLS
OR
OR
Q1 26
$220.6M
Q4 25
$225.9M
Q3 25
$219.0M
Q2 25
$228.8M
Q1 25
$213.4M
Q4 24
$232.6M
Q3 24
$229.6M
Q2 24
$233.8M
Debt / Equity
EOLS
EOLS
OR
OR
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
22.00×
Q3 24
20.58×
Q2 24
6.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EOLS
EOLS

Product revenue, net$72.7M99%
Service revenue$390.0K1%

OR
OR

Segment breakdown not available.

Related Comparisons